Advanced Search

Home > Journals > Minerva Pneumologica > Past Issues > Minerva Pneumologica 2006 September;45(3) > Minerva Pneumologica 2006 September;45(3):145-52



A Journal on Diseases of the Respiratory System

Official Journal of the Italian Society of Thoracic Endoscopy
Indexed/Abstracted in: EMBASE, Scopus

Frequency: Quarterly

ISSN 0026-4954

Online ISSN 1827-1723


Minerva Pneumologica 2006 September;45(3):145-52


Bronchial asthma and gastroesophageal reflux

Carpagnano G. E. 1, Spanevello A. 2, Dimatteo C. 1, Foschino Barbaro M. P. 1

1 Cattedra di Malattie dell’Apparato Respiratorio Dipartimento di Scienze Mediche del Lavoro Università degli Studi di Foggia, Foggia
2 Divisione di Pneumologia Fondazione Salvatore Maugeri Istituto Scientifico di Cassano delle Murge, Bari

Asthma is an inflammatory disease of the airways characterized by increased airway reactivity with airflow obstruction. It is exacerbated by multiple triggers and one common, often overlooked trigger, is gastroesophageal reflux (GER). The prevalence of GER in asthma is estimated at between 34% and 80%. The relationship between the occurrence of gastroesophageal disorders and of changes in respiratory function has been known for long time even though the mechanism by which intra-esophageal acid regurgitation from stomach can produce bronchoconstrinction, heightened bronchial hyperresponsiveness and other asthma symptoms is still debated. Some patients may not have reflux symptoms, leaving the clinician unaware that GER reflux may be a pathogenetic factor in asthma, but patients with refractory asthma generally should be evaluated for gastroesophageal reflux. In this review we discussed the epidemiology, the pahogenetic hypotheses, the clinical, biological and diagnostic indicators and the therapeutic strategies of GER-related asthma.

language: Italian


top of page